secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)
CIK:        0001310488
Form:       8-K
Filed at:   2026-06-18T12:28:29+00:00
Accession:  0001091818-26-000084
Event type: other_material
Sentiment:  neutral
Materiality: 0.90
Item codes: 5.01, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioForce Nanosciences changes control; sells 79.65% stake; pivots to oil & gas
------------------------------------------------------------------------------

- Merle Ferguson sold 26.7M shares (79.65% of outstanding) to Nexus Capital Investments for $400,000 on April 15, 2026.
- Co-CEOs Steven Gagnon and John LaViolette, and VP Sasha Shapiro resigned effective June 17, 2026.
- Scott Mager appointed as Director effective June 15, 2026; Richard Kaiser named interim CEO.
- Company shifts business from vitamin supplements to oil and gas industry; evaluating opportunities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1310488/000109181826000084/0001091818-26-000084-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1310488/000109181826000084/bfnh-06182026_8k.htm
  HTML page:      https://secwatch.observer/filing/0001091818-26-000084

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer